FDA Classifies Medline Neonatal Heated Wire Breathing Circuit Recall as Class II
核心洞察
The FDA assigned a Class II severity rating to the recall of Medline's Hudson RCI (搜索) neonatal and infant heated wire breathing circuits, placing it in the middle of the agency's three-tier risk system.
The recall stems from sporadic failures at the heated-wire connector, where circuits can discolor, melt, smoke, or emit a burning odor at the point of connection to the Neptune humidifier.
A built-in safety feature cuts power to the heated wires when electrical abnormalities are detected, so respiratory gas flow continues and only the warming and humidification function stops.
Federal regulators have assigned a formal severity rating to the recall of neonatal and infant breathing circuits pulled from hospitals nationwide, placing it in the middle of the FDA's three-tier system rather than the most serious category. The agency classified the Medline recall of Hudson RCI (搜索) neonatal and infant heated wire breathing circuits as Class II, a designation that applies to devices that may cause temporary or reversible health problems, or, though unlikely, serious health problems.
The classification does not change what hospitals were already told to do. Affected circuits still must be identified, quarantined, and destroyed once the recall response form is complete. What changes is the risk estimate attached to the event, and that is the piece parents of infants in neonatal intensive care have been waiting on.
A Classification That Narrows the Risk Estimate
The sequence matters for reading this correctly. On August 21, the FDA issued an Early Alert, a communication the agency uses to flag a potentially high-risk device issue while its review is still underway. It is a warning issued before conclusions are reached, not a finding. The Class II classification, posted on September 1, is the conclusion of that review.
In practical terms, regulators looked at the failure mode and the reported outcomes and determined the probability of serious harm is low. Medline had not reported any serious injuries or deaths associated with the issue as of July 31, according to the FDA recall notice.
The contrast with a Class I event is instructive. A separate breathing circuit recall involving Hamilton Medical (搜索) ventilators received the most serious classification after four reported serious injuries. Both involve circuits, but the tiers are not the same, and the difference is the agency's judgment about likely harm.
The Underlying Defect
The underlying defect is worth understanding plainly. Medline received reports of sporadic failures at the heated wire connector, sometimes called the pigtail, where the circuit meets the Neptune humidifier. Affected connectors could show discoloration, melting, smoke, a burning odor or other signs of localized thermal damage.
A safety feature limits how far that can escalate. The humidifier continuously monitors the heated wire circuit and automatically cuts power to the heated wires when it detects electrical abnormalities. Respiratory gas keeps flowing to the infant. Only the heating function stops.
Cold, Dry Gas Is the Real Danger to a Newborn
The consequences flow from that loss of heating rather than from fire. Heated wire circuits exist because delivering cold, dry gas to a small airway can cause harm. Gas that is inadequately warmed and humidified can dry and damage the airway lining, which the FDA notes can predispose an infant to bronchospasm (搜索), thickened secretions, and airway obstruction.
Loss of heated wire function can also increase condensation inside the tubing, a phenomenon clinicians call rainout, which can cause unintended positive end-expiratory pressure, circuit obstruction, or pooled fluid entering the airway. Colder, drier gas raises the risk of cold stress, which increases oxygen consumption and can worsen respiratory distress (搜索) in a baby who already has very little reserve.
The agency's instruction to clinical teams is direct: "Increased vigilance is recommended for monitoring your ventilator, circuit, and humidification systems."
The Labeling Problem Hospitals Still Face
One complication from the earlier stage has not gone away. Some affected circuits carry item numbers that do not match the numbers listed in Medline's original notice, which was sent to customers on July 13, with follow-up letters on July 27 and August 5.
The reason is a manufacturing transition. Circuits produced before January 2024 carry a Teleflex label and Teleflex item number, in formats such as 780-07 or 880-14KIT. Circuits produced from January 2024 onward carry a Medline label and Medline item number, in formats such as HUD78007 or HUD88014KIT. A facility checking against only one numbering system could miss affected stock sitting on a shelf.
Eighteen product configurations appear on the agency's summary table, spanning single-limb and dual-limb neonatal circuits and Iso-Shield infant circuits. Distributors who resold or transferred the product are instructed to notify their own customers and include those quantities on the response form.
Reporting Channels and Next Steps
The FDA has not announced further action beyond the classification, and no expansion of the recall has been reported. Because Class II is the conclusion of the agency's review rather than an interim step, the most likely future development would be new adverse event reports rather than a reclassification.
Several things remain unconfirmed. The total number of affected circuits in circulation has not been published. Whether any patient experienced a clinical consequence that was never linked to the connector fault is unknown, which is a general limitation of passive reporting systems. The company reported no serious injuries or deaths as of July 31, and that date is the boundary of what is currently known rather than a permanent finding.
Hospitals and clinicians in the United States with questions can contact Medline at 866-359-1704 or by email at recalls@medline.com. Device problems can be reported through the MedWatch adverse event reporting program.